- Net Income: 3.18 billion rupees, down 45% year-on-year, missing the estimate of 5.26 billion rupees.
- Revenue: 48.3 billion rupees, a decrease of 2.8% year-on-year, falling short of the 49.97 billion rupees estimate.
- Total Costs: Increased by 4.5% year-on-year to 46.2 billion rupees.
- Raw Material Costs: Rose by 4.8% year-on-year to 3.72 billion rupees, below the 4.16 billion rupees estimate.
- Power and Fuel Expense: Decreased by 7.2% year-on-year to 14.1 billion rupees, slightly below the 14.36 billion rupees estimate.
- Freight and Forwarding Expenses: Went up by 5.7% year-on-year to 11.2 billion rupees, higher than the 10.68 billion rupees estimate.
- Other Income: Decreased by 17% year-on-year to 1.35 billion rupees.
- Analyst Recommendation: 21 buys, 13 holds, 7 sells.
A look at Shree Cement Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 5 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts predict a positive long-term outlook for Shree Cement, with a solid overall performance indicated by the Smart Scores. The company’s high resilience score of 5 suggests it is well-positioned to weather economic uncertainties. With a score of 3 in value, dividend, growth, and momentum, Shree Cement demonstrates consistency across various factors, indicating stable investment potential.
Shree Cement Ltd., a manufacturer of cement and related products, focuses its sales predominantly in Northern India under its own brand names. With balanced scores in key areas such as growth and value, the company presents as a reliable player in the cement industry. Its consistent performance across multiple factors bodes well for its long-term prospects.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
